{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:41:36Z","timestamp":1790361696585,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012322","name":"Universiti Pertahanan Nasional Malaysia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>MicroRNA-155 (miR-155) has emerged as a pivotal regulator in the development of hypertension. However, its role in the mechanism underlying hypertension remains incompletely defined, especially in vascular inflammation and dysfunction. This review synthesizes and evaluates the published literature on the role of miR-155 in the regulation of inflammation, endothelial dysfunction (ED), and vascular smooth muscle cells (VSMCs) function in essential hypertension (EH). We evaluated experimental and clinical studies investigating the expression patterns, molecular targets, and pathways involving miR-155 in endothelial cells (EC), VSMCs in hypertensive conditions. MiR-155 is consistently upregulated in the circulating and tissue of hypertensive models and patients. MiR-155 intensifies inflammation by suppressing endothelial nitric oxide synthase (eNOS) production, enhancing nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB) signaling, and promoting pro-inflammatory cytokine expression. In EC, miR-155 directly targets eNOS, leading to impaired nitric oxide (NO) bioavailability and vasodilation by inhibiting the phosphatidylinositol-3-kinase\/serine\/threonine kinase (PI3K\/Akt) pathway. miR-155 modulates the renin-angiotensin-aldosterone system (RAAS) by directly targeting angiotensin II Type 1 receptor (AT1R) mRNA, reducing its expression and attenuating angiotensin II (Ang II) signaling. In VSMCs, it promotes phenotypic switching and contributes to vascular remodeling through the soluble guanylate cyclase\/cyclic guanosine monophosphate (sGC\/cGMP) pathway. These coordinated actions foster a pro-inflammatory, vasoconstrictive state that underpins hypertension development. MiR-155 acts as a central molecular link between inflammation and vascular dysfunction in essential hypertension by modulating endothelial function, vascular inflammation, and smooth muscle cell behavior. Its modulation highlights miR-155 as a potential therapeutic target to restore endothelial homeostasis and limit vascular damage in hypertensive patients.<\/jats:p>","DOI":"10.1007\/s11033-026-12039-8","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:02:22Z","timestamp":1780128142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MicroRNA-155 at the crossroads of inflammation and vascular dysfunction in essential hypertension"],"prefix":"10.1007","volume":"53","author":[{"given":"Norizam","family":"Salamt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Aishah","family":"Che Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nik Noorul Shakira","family":"Mohamed Shakrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azizah","family":"Ugusman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"12039_CR1","unstructured":"World Health Organization. Hypertension - Key Facts [Internet]. WHO Publications (2023) https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hypertension. Accessed 15 December 2025"},{"key":"12039_CR2","unstructured":"National Institute for Health and Care Excellence (2024) Hypertension in adults: diagnosis and management"},{"issue":"12","key":"12039_CR3","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A et al (2023) 2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension. J Hypertens 41(12):1874\u20132071. https:\/\/doi.org\/10.1097\/HJH.0000000000003480","journal-title":"J Hypertens"},{"key":"12039_CR4","unstructured":"World Health Organization. Global Report on Hypertension: The Silent Killer [Internet]. WHO Publications (2023) https:\/\/www.who.int\/publications\/i\/item\/9789240081062. Accessed 15 December 2025"},{"key":"12039_CR5","unstructured":"Iqbal MA, Jamal SF (2023) Essential hypertension. [Internet]. Stat Pearls, NCBI Bookshelf. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539859\/ Accessed 15 December 2025"},{"issue":"4","key":"12039_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41569-020-00466-4","volume":"18","author":"S Padmanabhan","year":"2021","unstructured":"Padmanabhan S, Dominiczak AF (2021) Genomics of hypertension: the road to precision medicine. Nat Rev Cardiol 18(4):235\u2013250. https:\/\/doi.org\/10.1038\/s41569-020-00466-4","journal-title":"Nat Rev Cardiol"},{"key":"12039_CR7","doi-asserted-by":"publisher","unstructured":"Liu J, Zhou F, Guan Y, Meng F, Zhao Z, Su Q et al (2022) The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis. Cells 11(3). https:\/\/doi.org\/10.3390\/cells11030572","DOI":"10.3390\/cells11030572"},{"issue":"681","key":"12039_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11033-025-10756-0","volume":"52","author":"F Wang","year":"2025","unstructured":"Wang F, Shi Z, Yu Z, Lu B, Mu G (2025) MicroRNA-451: A multifaceted regulator in cerebral and cardiac ischemia-reperfusion injury - from molecular mechanisms to therapeutic potential. Mol Biol Rep 52(681):1\u201311. https:\/\/doi.org\/10.1007\/s11033-025-10756-0","journal-title":"Mol Biol Rep"},{"key":"12039_CR9","doi-asserted-by":"publisher","first-page":"107296","DOI":"10.1016\/j.carpath.2020.107296","volume":"50","author":"S Kalayinia","year":"2021","unstructured":"Kalayinia S, Arjmand F, Maleki M, Malakootian M, Singh CP (2021) MicroRNAs: roles in cardiovascular development and disease. Cardiovasc Pathol 50:107296. https:\/\/doi.org\/10.1016\/j.carpath.2020.107296","journal-title":"Cardiovasc Pathol"},{"key":"12039_CR10","first-page":"181","volume":"82","author":"L He","year":"2025","unstructured":"He L, Liu Y, Widlansky ME, Kriegel AJ, Liang M (2025) microRNA Hypertens Hypertens 82:181\u2013184","journal-title":"microRNA Hypertens Hypertens"},{"key":"12039_CR11","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00011-022-01643-6","volume":"71","author":"W-D Xu","year":"2022","unstructured":"Xu W-D, Feng S-Y, Huang A-F (2022) Role of miR\u2009\u2013\u2009155 in inflammatory autoimmune diseases: a comprehensive review. Inflamm Res 71:1501\u20131517. https:\/\/doi.org\/10.1007\/s00011-022-01643-6","journal-title":"Inflamm Res"},{"key":"12039_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12986-020-00459-7","volume":"17","author":"L Gou","year":"2020","unstructured":"Gou L, Liu G, Ma R, Regmi A, Zeng T, Zheng J et al (2020) High-fat-induced inflammation in vascular endothelium can be improved by Abelmoschus esculentus and metformin via increasing the expressions of miR-146a and miR-155. Nutr Metab (Lond) 17:35. https:\/\/doi.org\/10.1186\/s12986-020-00459-7","journal-title":"Nutr Metab (Lond)"},{"issue":"10","key":"12039_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2025.5681","volume":"57","author":"X Zhao","year":"2026","unstructured":"Zhao X, Wang P (2026) Interpretation of the molecular mechanism and therapeutic potential of microRNA \u2013 155 in cardiovascular and cerebrovascular diseases (Review). Int J Mol Med 57(10):1\u201322. https:\/\/doi.org\/10.3892\/ijmm.2025.5681","journal-title":"Int J Mol Med"},{"key":"12039_CR14","doi-asserted-by":"publisher","first-page":"200355","DOI":"10.1016\/j.ijcrp.2024.200355","volume":"24","author":"R-L Zhang","year":"2025","unstructured":"Zhang R-L, Wang W-M, Li J-Q, Li R-W, Zhang J, Wu Y et al (2025) The role of miR-155 in cardiovascular diseases: Potential diagnostic and therapeutic targets. Int J Cardiol Cardiovasc Risk Prev [Internet] 24:200355. https:\/\/doi.org\/10.1016\/j.ijcrp.2024.200355","journal-title":"Int J Cardiol Cardiovasc Risk Prev [Internet]"},{"key":"12039_CR15","doi-asserted-by":"publisher","unstructured":"Yan W, Chen R, Zhao Y, Zhang X, Li X (2025) MicroRNA-155-5p rs767649 polymorphism is associated with susceptibility to essential hypertension in the chinese tibetan population in the Gannan area. Artery Res 31(1). https:\/\/doi.org\/10.1007\/s44200-025-00070-2","DOI":"10.1007\/s44200-025-00070-2"},{"issue":"5","key":"12039_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41371-019-0250-7","volume":"34","author":"Y Huang","year":"2020","unstructured":"Huang Y, Huang C, Zhang B, Feng Y (2020) Association of circulating miR-155 expression level and inflammatory markers with white coat hypertension. J Hum Hypertens 34(5):397\u2013403. https:\/\/doi.org\/10.1038\/s41371-019-0250-7","journal-title":"J Hum Hypertens"},{"issue":"2","key":"12039_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ajh.2010.211","volume":"24","author":"G Ceolotto","year":"2011","unstructured":"Ceolotto G, Papparella I, Bortoluzzi A, Strapazzon G, Ragazzo F, Bratti P et al (2011) Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens 24(2):241\u2013246. https:\/\/doi.org\/10.1038\/ajh.2010.211","journal-title":"Am J Hypertens"},{"issue":"1","key":"12039_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1080\/0886022X.2021.1915800","volume":"43","author":"SP Kara","year":"2021","unstructured":"Kara SP, Ozkan G, Y\u0131lmaz A, Bayrak\u00e7\u0131 N, G\u00fczel S, Geyik E (2021) MicroRNA 21 and microRNA 155 levels in resistant hypertension, and their relationships with aldosterone. Ren Fail 43(1):676\u2013683. https:\/\/doi.org\/10.1080\/0886022X.2021.1915800","journal-title":"Ren Fail"},{"issue":"3","key":"12039_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3109\/10641963.2015.1116551","volume":"38","author":"Y Huang","year":"2016","unstructured":"Huang Y, Chen J, Zhou Y, Tang S, Li J, Yu X et al (2016) Circulating miR155 expression level is positive with blood pressure parameters: Potential markers of target-organ damage. Clin Exp Hypertens 38(3):331\u2013336. https:\/\/doi.org\/10.3109\/10641963.2015.1116551","journal-title":"Clin Exp Hypertens"},{"key":"12039_CR20","doi-asserted-by":"publisher","unstructured":"DuPont JJ, McCurley A, Davel AP, McCarthy J, Bender SB, Hong K et al (2016) Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging. JCI Insight 1(14). https:\/\/doi.org\/10.1172\/jci.insight.88942","DOI":"10.1172\/jci.insight.88942"},{"issue":"6","key":"12039_CR21","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/HYPERTENSIONAHA.112.197301","volume":"60","author":"H-X Sun","year":"2012","unstructured":"Sun H-X, Zeng D-Y, Li R-T, Pang R-P, Yang H, Hu Y-L et al (2012) Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase. Hypertens 60(6):1407\u20131414. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.197301","journal-title":"Hypertens"},{"issue":"21","key":"12039_CR22","doi-asserted-by":"publisher","first-page":"7431","DOI":"10.26355\/eurrev-201811-16283","volume":"22","author":"D Xu","year":"2018","unstructured":"Xu D, Liao R, Wang X-X, Cheng Z (2018) Effects of miR-155 on hypertensive rats via regulating vascular mesangial hyperplasia. Eur Rev Med Pharmacol Sci 22(21):7431\u20137438. https:\/\/doi.org\/10.26355\/eurrev-201811-16283","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"12039_CR23","doi-asserted-by":"publisher","unstructured":"Tong Y, Zhou M-H, Li S-P, Zhao H-M, Zhang Y-R, Chen D et al (2023) MiR-155-5p attenuates vascular smooth muscle cell oxidative stress and migration via inhibiting BACH1 expression. Biomedicines 11(6). https:\/\/doi.org\/10.3390\/biomedicines11061679","DOI":"10.3390\/biomedicines11061679"},{"issue":"6","key":"12039_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/jir.2018.0155","volume":"39","author":"G Mahesh","year":"2019","unstructured":"Mahesh G, Biswas R (2019) MicroRNA-155: A Master Regulator of Inflammation. J Interf Cytokine Res 39(6):321\u2013330. https:\/\/doi.org\/10.1089\/jir.2018.0155","journal-title":"J Interf Cytokine Res"},{"issue":"April","key":"12039_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.00625","volume":"11","author":"S Pasca","year":"2020","unstructured":"Pasca S, Jurj A, Petrushev B, Tomuleasa C (2020) MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases. Front Immunol 11(April):1\u20137. https:\/\/doi.org\/10.3389\/fimmu.2020.00625","journal-title":"Front Immunol"},{"key":"12039_CR26","doi-asserted-by":"publisher","unstructured":"Dawson O, Piccinini AM (2025) miR-155-3p: processing by-product or rising star in immunity and cancer ? Open Biochem J 12. https:\/\/doi.org\/10.1098\/rsob.220070\/935563\/rsob.220070.pdf","DOI":"10.1098\/rsob.220070\/935563\/rsob.220070.pdf"},{"key":"12039_CR27","doi-asserted-by":"publisher","unstructured":"Xue X, Wang J, Fu K, Dai S, Wu R, Peng C (2023) The role of miR-155 on liver diseases by modulating immunity, inflammation and tumorigenesis. Int Immunopharmacol 116. https:\/\/doi.org\/10.1016\/j.intimp.2023.109775","DOI":"10.1016\/j.intimp.2023.109775"},{"key":"12039_CR28","unstructured":"Xu CC, Han WQ, Xiao B, Li NN, Zhu DL, Gao PJ (2008) Differential expression of microRNAs in the aorta of spontaneously hypertensive rats. Acta Physiol Sin. 60(4):553\u2013560"},{"key":"12039_CR29","doi-asserted-by":"publisher","unstructured":"Bruen R, Fitzsimons S, Belton O (2019) miR-155 in the Resolution of Atherosclerosis. Front Pharmacol 10. https:\/\/doi.org\/10.3389\/fphar.2019.00463","DOI":"10.3389\/fphar.2019.00463"},{"key":"12039_CR30","doi-asserted-by":"publisher","unstructured":"Park M, Choi S, Kim S, Kim J, Lee D-K, Park W et al (2019) NF-\u03baB-responsive miR-155 induces functional impairment of vascular smooth muscle cells by downregulating soluble guanylyl cyclase. Exp Mol Med 51(2). https:\/\/doi.org\/10.1038\/s12276-019-0212-8","DOI":"10.1038\/s12276-019-0212-8"},{"key":"12039_CR31","doi-asserted-by":"publisher","unstructured":"Lin S, Yang Y, Zhou Z, Li W, Wang X, Liu Y et al (2024) Regulation mechanism of microRNAs in cardiac cells-derived exosomes in cell crosstalk. Front Pharmacol 1\u201313. https:\/\/doi.org\/10.3389\/fphar.2024.1399850","DOI":"10.3389\/fphar.2024.1399850"},{"issue":"9","key":"12039_CR32","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1097\/HJH.0000000000002508.Vascular","volume":"38","author":"L Zanoli","year":"2020","unstructured":"Zanoli L, Briet M, Philippe J, Guimar\u00e3es P, Kaisa M (2020) Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society. J Hypertens 38(9):1682\u20131698. https:\/\/doi.org\/10.1097\/HJH.0000000000002508.Vascular","journal-title":"J Hypertens"},{"key":"12039_CR33","doi-asserted-by":"publisher","first-page":"108799","DOI":"10.1016\/j.biopha.2019.108799","volume":"114","author":"J Yang","year":"2019","unstructured":"Yang J, Si D, Zhao Y, He C, Yang P (2019) S-amlodipine improves endothelial dysfunction via the RANK\/RANKL\/OPG system by regulating microRNA-155 in hypertension. Biomed Pharmacother 114:108799. https:\/\/doi.org\/10.1016\/j.biopha.2019.108799","journal-title":"Biomed Pharmacother"},{"key":"12039_CR34","doi-asserted-by":"publisher","unstructured":"Wang X, Han W, Zhang Y, Zong Y, Tan N, Zhang Y et al (2022) Soluble eepoxide hydrolase inhibitor t-AUCB ameliorates vascular endothelial dysfunction by influencing the NF-\u03baB\/miR-155-5p\/eNOS\/NO\/I\u03baB cycle in hypertensive rats. Antioxidants 11(7). https:\/\/doi.org\/10.3390\/antiox11071372","DOI":"10.3390\/antiox11071372"},{"key":"12039_CR35","doi-asserted-by":"publisher","unstructured":"Mann M, Mehta A, Zhao JL, Lee K, Marinov GK, Garcia-Flores Y et al (2017) An NF-\u03baB-microRNA regulatory network tunes macrophage inflammatory responses. Nat Commun [Internet]. ;8(851). Available from: https:\/\/doi.org\/10.1038\/s41467-017-00972-z","DOI":"10.1038\/s41467-017-00972-z"},{"issue":"20","key":"12039_CR36","doi-asserted-by":"publisher","first-page":"6591","DOI":"10.26355\/eurrev_201810_16133","volume":"22","author":"D-F Liu","year":"2018","unstructured":"Liu D-F, Li S-M, Zhu Q-X, Jiang W (2018) The involvement of miR-155 in blood pressure regulation in pregnant hypertension rat via targeting FOXO3a. Eur Rev Med Pharmacol Sci 22(20):6591\u20136598. https:\/\/doi.org\/10.26355\/eurrev_201810_16133","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"12039_CR37","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1002\/jcb.25234","volume":"116","author":"Y Liu","year":"2015","unstructured":"Liu Y, Pan Q, Zhao Y, He C, Bi K, Chen Y et al (2015) MicroRNA-155 regulates ROS production, NO generation, apoptosis and multiple functions of human brain microvessel endothelial cells under physiological and pathological conditions. J Cell Biochem 116(12):2870\u20132881. https:\/\/doi.org\/10.1002\/jcb.25234","journal-title":"J Cell Biochem"},{"key":"12039_CR38","doi-asserted-by":"crossref","unstructured":"Kopaliani I, Elsaid B, Speier S, Deussen A (2024) Immune and metabolic mechanisms of endothelial dysfunction. Int J Mol Sci 25. 10.3390\/ ijms252413337","DOI":"10.3390\/ijms252413337"},{"key":"12039_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41569-022-00770-1","volume":"20","author":"E Trimm","year":"2023","unstructured":"Trimm E, Red-horse K (2023) Vascular endothelial cell development and diversity. Nat Rev Cardiol 20:197\u2013210. https:\/\/doi.org\/10.1038\/s41569-022-00770-1","journal-title":"Nat Rev Cardiol"},{"key":"12039_CR40","doi-asserted-by":"publisher","unstructured":"Dro\u017cd\u017c D, Dro\u017cd\u017c M, W\u00f3jcik M (2023) Endothelial dysfunction as a factor leading to arterial hypertension. Pediatr Nephrol [Internet]. ;38(9):2973\u201385. Available from: https:\/\/doi.org\/10.1007\/s00467-022-05802-z","DOI":"10.1007\/s00467-022-05802-z"},{"key":"12039_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.vph.2015.03.005","volume":"71","author":"HN Siti","year":"2015","unstructured":"Siti HN, Kamisah Y, Kamsiah J (2015) The role of oxidative stress, antioxidants, and vascular inflammation in cardiovascular disease (a review). Vascul Pharmacol 71:40\u201356. https:\/\/doi.org\/10.1016\/j.vph.2015.03.005","journal-title":"Vascul Pharmacol"},{"key":"12039_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcla.24518","volume":"36","author":"R Wang","year":"2022","unstructured":"Wang R, Wei A, Zhang Y, Xu G, Nong X, Liu C et al (2022) Association between genetic variants of microRNA- \u00ad 21 and microRNA- \u00ad 155 and systemic lupus erythematosus: A case- \u00ad control study from a Chinese population. J Clin Lab Anal 36:1\u20139. https:\/\/doi.org\/10.1002\/jcla.24518","journal-title":"J Clin Lab Anal"},{"issue":"7","key":"12039_CR43","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1172\/JCI42946.phosphate","volume":"121","author":"C Besler","year":"2011","unstructured":"Besler C, Heinrich K, Rohrer L, Doerries C, Riwanto M, Shih DM et al (2011) Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest 121(7):2693\u20132708. https:\/\/doi.org\/10.1172\/JCI42946.phosphate","journal-title":"J Clin Invest"},{"issue":"3","key":"12039_CR44","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1113\/JP283208","volume":"601","author":"OS Kwon","year":"2023","unstructured":"Kwon OS, Noh SG, Park SH, Andtbacka RHI, Hyngstrom JR, Richardson RS (2023) Ageing and endothelium-mediated vascular dysfunction: the role of the NADPH oxidases. J Physiol Sci JPS 601(3):451\u2013467. https:\/\/doi.org\/10.1113\/JP283208","journal-title":"J Physiol Sci JPS"},{"key":"12039_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/5863617","volume":"2020","author":"K Jiang","year":"2020","unstructured":"Jiang K, Hu J, Luo G, Song D, Zhang P, Zhu J et al (2020) MiR-155-5p Promotes Oxalate- a nd calcium-induced kidney oxidative stress injury by suppressing MGP expression. Oxid Med Cell Longev 2020:1\u201314. https:\/\/doi.org\/10.1155\/2020\/5863617","journal-title":"Oxid Med Cell Longev"},{"key":"12039_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.123.032079","volume":"13","author":"M Zhao","year":"2024","unstructured":"Zhao M, Lei J, Deng F, Zhao C, Xu T, Ji B et al (2024) Gestational Hypoxia Impaired Endothelial Nitric Oxide Synthesis Via miR- 155- 5p\/ NADPH Oxidase\/Reactive Oxygen Species Axis in Male Offspring Vessels. J Am Heart Assoc 13:1\u201315. https:\/\/doi.org\/10.1161\/JAHA.123.032079","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"12039_CR47","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.atherosclerosis.2014.04.028","volume":"235","author":"D Hong","year":"2014","unstructured":"Hong D, Bai Y, Gao H, Wang X, Li L, Zhang G et al (2014) Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathway. Atherosclerosis 235(2):310\u2013317. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.04.028","journal-title":"Atherosclerosis"},{"issue":"1","key":"12039_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10741-019-09855-5","volume":"25","author":"NR Pugliese","year":"2019","unstructured":"Pugliese NR, Masi S, Taddei S (2019) The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure. Heart Fail Rev 25(1):31\u201342. https:\/\/doi.org\/10.1007\/s10741-019-09855-5","journal-title":"Heart Fail Rev"},{"key":"12039_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-48014-6","volume":"9","author":"C Schaeffer","year":"2019","unstructured":"Schaeffer C, Izzi C, Vettori A, Pasqualetto E, Cittaro D, Lazarevic D et al (2019) Autosomal dominant tubulointerstitial kidney disease with adult onset due to a novel renin mutation mapping in the mature protein. Sci Rep 9:1\u201311. https:\/\/doi.org\/10.1038\/s41598-019-48014-6","journal-title":"Sci Rep"},{"issue":"3","key":"12039_CR50","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.bmcl.2017.11.042","volume":"28","author":"J Wannberg","year":"2018","unstructured":"Wannberg J, Isaksson R, Ulf B, Maria B (2018) A convenient transesterification method for synthesis of AT2 receptor ligands with improved stability in human liver microsomes. Bioorg Med Chem Lett 28(3):519\u2013522. https:\/\/doi.org\/10.1016\/j.bmcl.2017.11.042","journal-title":"Bioorg Med Chem Lett"},{"key":"12039_CR51","doi-asserted-by":"publisher","unstructured":"Ghatage T, Goyal SG, Dhar A, Bhat A (2021) Novel therapeutics for the treatment of hypertension and its associated complications: peptide- and nonpeptide-based strategies. Hypertens Res [Internet]. ; Available from: https:\/\/doi.org\/10.1038\/s41440-021-00643-z","DOI":"10.1038\/s41440-021-00643-z"},{"key":"12039_CR52","doi-asserted-by":"publisher","unstructured":"Takaishi K, Kinoshita H, Kawashima S, Kawahito S (2021) Human vascular smooth muscle function and oxidative stress induced by NADPH oxidase with the clinical implications. Cells 10. https:\/\/doi.org\/10.3390\/cells10081947","DOI":"10.3390\/cells10081947"},{"key":"12039_CR53","doi-asserted-by":"publisher","first-page":"101527","DOI":"10.1155\/2015\/101527","volume":"2015","author":"M Pacurari","year":"2015","unstructured":"Pacurari M, Tchounwou PB (2015) Role of micrornas in renin-angiotensin-aldosterone system-mediated cardiovascular inflammation and remodeling. Int J Inflam 2015:101527. https:\/\/doi.org\/10.1155\/2015\/101527","journal-title":"Int J Inflam"},{"key":"12039_CR54","doi-asserted-by":"publisher","unstructured":"Singh A, Singh K (2024) Pathology of the Renin-Angiotensin-Aldosterone System. Renin-Angiotensin-Aldosterone System-Latest Trends. IntechOpen, pp 1\u201342. https:\/\/doi.org\/10.5772\/intechopen.1007937","DOI":"10.5772\/intechopen.1007937"},{"key":"12039_CR55","doi-asserted-by":"crossref","unstructured":"Improta-Caria AC, Aras MG, Nascimento L, De Sousa RAL, Aras-J\u00fanior R, de Souza BS (2021) MicroRNAs Regulating Renin-Angiotensin-Aldosterone System, Sympathetic Nervous System and Left Ventricular Hypertrophy in Systemic Arterial Hypertension. Biomolecules [Internet] 11(12). 10.3390\/ biom11121771","DOI":"10.3390\/biom11121771"},{"issue":"6","key":"12039_CR56","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.bbadis.2019.02.014","volume":"1865","author":"Y Yuan","year":"2019","unstructured":"Yuan Y, Wang J, Chen Q, Wu Q, Deng W, Zhou H et al (2019) Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling. Biochim Biophys Acta - Mol Basis Dis 1865(6):1421\u20131427. https:\/\/doi.org\/10.1016\/j.bbadis.2019.02.014","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"issue":"2","key":"12039_CR57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/1470320313503693","volume":"15","author":"L Yang","year":"2014","unstructured":"Yang L, Liu G, Zhu G, Liu H, Guo R, Qi F et al (2014) MicroRNA-155 inhibits angiotensin II-induced vascular smooth muscle cell proliferation. J Renin-Angiotensin-Aldosterone Syst 15(2):109\u2013116. https:\/\/doi.org\/10.1177\/1470320313503693","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"1334","key":"12039_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-01392-1","volume":"7","author":"C Rippe","year":"2017","unstructured":"Rippe C, Zhu B, Krawczyk KK, Bavel E, Van, Albinsson S, Sj\u00f6lund J et al (2017) Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway. Sci Rep 7(1334):1\u201313. https:\/\/doi.org\/10.1038\/s41598-017-01392-1","journal-title":"Sci Rep"},{"key":"12039_CR59","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1152\/ajprenal.00535.2016","volume":"313","author":"E Mehaffey","year":"2017","unstructured":"Mehaffey E, Majid DSA (2017) Tumor necrosis factor-a, kidney function, and hypertension. Am J Physiol Physiol 313:1005\u20131008. https:\/\/doi.org\/10.1152\/ajprenal.00535.2016","journal-title":"Am J Physiol Physiol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12039-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12039-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12039-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:02:26Z","timestamp":1780128146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12039-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12039"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12039-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study does not require formal ethical approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"863"}}